Trial
NCT06869278
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators
Nanjing Legend Biotech Co.
Condition
Multiple Sclerosis (MS)
Intervention
LCAR-AIO T cells
Why stopped
Legend discontinues the development of the IMP.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-24